GL1X · GenesisL1 explorer

MolNFT v1 · #176826 · protein

Human JMJD5 in complex with mn and 5-((4-PHENYLBUTYL)AMINO)PYRIDINE-2, 4-dicarboxylic acid.

7DYU · Bifunctional peptidase and arginyl-hydroxylase JMJD5: “Human JMJD5 in complex with mn and 5-((4-PHENYLBUTYL)AMINO)PYRIDINE-2, 4-dicarboxylic acid.”. X-ray diffraction, 2 ligands (HR9, MN), 1 pocket (best druggability 0.58). MolNFT…

PDB
7DYU
Type
protein
Length
228 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bifunctional peptidase and arginyl-hydroxylase JMJD5
EC
1.14.11.-, 3.4.-.-
UniProt
Q8N371
Ligands
HR9, MN
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.-, 3.4.-.-)protein22828% helix, 33% strandQ8N371

Ligands and binding sites

  • HR9 · 5-(4-phenylbutylamino)pyridine-2,4-dicarboxylic acid · ligand · chains A
  • MN · Manganese (II) ion · metal · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12260.580.7929MN, HR9

Compared structures

  • 7DYU · Human JMJD5 in complex with MN and 5-((4-phenylbutyl)amino)pyridine-2,4-dicarboxylic acid. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8N371 · AlphaFold monomer V2.0 prediction for bifunctional peptidase and arginyl-hydroxylase… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.